A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer.
Year: 1999
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: T S Mang, R Allison, G Hewson, W Snider, R Moskowitz
Institution: Buffalo General Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2341300569